DNA.WS
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
DNA.WS
Delisted
DNA.WS was delisted on the 3rd of September, 2024.
33 hedge funds and large institutions have $1.83M invested in Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
33
Holding in Top 10
–
Calls
$85K
Puts
–
Top Buyers
| 1 | +$139K | |
| 2 | +$41.7K | |
| 3 | +$11.5K | |
| 4 |
LC
Lindbrook Capital
Calabasas,
California
|
+$6.25K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$5.8K |
Top Sellers
| 1 | -$8.9M | |
| 2 | -$83.6K | |
| 3 | -$71.8K | |
| 4 |
TCA
Taconic Capital Advisors
New York
|
-$23.1K |
| 5 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
-$6.55K |